Here are the top stories from the last week:
Industry Updates
Alto, Cencora Team Up to Optimize Patient Experience for Specialty Medications
Alto and Cencora have partnered to enhance patient access to specialty medications, aiming to improve the overall patient experience. Learn more »
MyPhysician360, Kare PharmTech Come Together to Support Pharmacies
Myphysician360 and Kare PharmTech have partnered to support pharmacies, aiming to transform healthcare delivery to customers. Learn more »
Study Reveals Virtual Reality Effectively Educates Pharmacists on Continuous Glucose Monitors
Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices. Learn more »
Pharmacists Play Important Role in Nutrition Education
Educating patients about the nutrition facts label and integrating food pharmacies are examples of pharmacist opportunities. Learn more »
NACDS Celebrates Nutrition Month with Nourish My Health Digital Campaign
The National Association of Chain Drug Stores (NACDS) is promoting the role of member pharmacies in providing essential health and wellness services through the Nourish My Health Digital Campaign. Learn more »
Optum Rx Cuts Back Prior Authorizations by 10%
Optum Rx has reduced prior authorizations by 10%, aiming to streamline processes and improve patient access to medications. Learn more »
NCPA Reacts to Optum Rx Cost-Plus Announcement: Actions Will Speak Louder Than Words
The National Community Pharmacists Association (NCPA) issued a statement in response to OptumRx’s announcement regarding cost-plus pricing, emphasizing that the effectiveness of such initiatives will depend on their implementation and impact on community pharmacies. Learn more »
Industry Leaders Are ‘All In’ on Pharmacy Interoperability
Nationwide efforts are underway to advance pharmacy patient care services at scale, focusing on interoperability. Learn more »
Drug Updates
FDA Gives Lupin Tentative Nod for Generic Firdapse
The FDA has given Lupin a tentative approval for its generic version of Firdapse, which is used to treat Lambert-Eaton myasthenic syndrome in adults and pediatric patients aged 6 and older. Learn more »
Avenacy Introduces 5 Antibiotic Generics
U.S.-based pharmaceutical company Avenacy has launched five new injectable antibiotic products, expanding its generic drug offerings. Learn more »
Ustekinumab Biosimilar Launches in the US
The launch of ustekinumab-stba following its FDA approval expands patient access to this therapy for Crohn’s disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. Learn more »
Concerns Surrounding Compounded GLP-1s Mount as Shortages of Tirzepatide, Semaglutide End
An expert roundtable discussed what consumers and pharmacists should be aware of as compounded versions of glucagon-like peptide-1 receptor agonists continue to proliferate. Learn more »